Franklin Genomic Advancem... (HELX)
CBOE: HELX
· Real-Time Price · USD
30.85
0.74 (2.46%)
At close: Sep 11, 2025, 2:54 PM
HELX Holdings List
As of Sep 10, 2025
The Franklin Genomic Advancements ETF is an equity ETF with a total of 49 individual holdings.
The top holdings are Natera at 6.31%, Alnylam Pharmaceuticals at 5.04%, Medpace s at 4.51%, Guardant Health at 4.39%, and Insmed Incorporated at 4.38%.
49
40.31%
Equity
16.85M
30.50
0.5000%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | NTRA | Natera, Inc. | 173.81 | +2.37% | 6.04K | 6.31% |
| 2 | ALNY | Alnylam Pharmac... | 468.58 | -0.16% | 1.76K | 5.04% |
| 3 | MEDP | Medpace Holding... | 497.59 | +4.38% | 1.57K | 4.51% |
| 4 | GH | Guardant Health... | 56.80 | +0.40% | 12.45K | 4.39% |
| 5 | INSM | Insmed Incorpor... | 145.78 | -0.1% | 5.02K | 4.38% |
| 6 | UTHR | United Therapeu... | 404.84 | +2.10% | 1.42K | 3.40% |
| 7 | TEM | Tempus AI, Inc. | 88.84 | +13.66% | 6.69K | 3.21% |
| 8 | KRYS | Krystal Biotech... | 144.36 | +5.02% | 3.74K | 3.13% |
| 9 | LGND | Ligand Pharmace... | 167.06 | +0.66% | 3.07K | 3.01% |
| 10 | AZN | AstraZeneca PLC | 81.10 | +0.36% | 6.07K | 2.93% |
| 11 | CTVA | Corteva, Inc. | 72.96 | +1.64% | 6.8K | 2.92% |
| 12 | BBIO | BridgeBio Pharm... | 52.60 | -0.68% | 8.94K | 2.84% |
| 13 | ADPT | Adaptive Biotec... | 13.49 | +8.62% | 36.86K | 2.76% |
| 14 | LLY | Eli Lilly and C... | 755.95 | +0.18% | 560 | 2.49% |
| 15 | CDNS | Cadence Design ... | 354.81 | +4.81% | 1.13K | 2.42% |
| 16 | BNTX | BioNTech SE | 104.31 | +3.28% | 3.67K | 2.22% |
| 17 | WGS | GeneDx Holdings... | 125.89 | +2.19% | 2.54K | 1.90% |
| 18 | EXAS | Exact Sciences ... | 56.01 | +2.26% | 5.26K | 1.73% |
| 19 | ARGNF | argenx SE | 697.42 | 0.00% | 349 | 1.58% |
| 20 | LZAGF | Lonza Group AG | 719.14 | +2.79% | 343 | 1.45% |
| 21 | RARE | Ultragenyx Phar... | 31.23 | -0.19% | 7.13K | 1.33% |
| 22 | LH | Labcorp Holding... | 279.89 | +2.55% | 765 | 1.26% |
| 23 | CRL | Charles River L... | 159.73 | +4.21% | 1.33K | 1.24% |
| 24 | DOCS | Doximity, Inc. | 70.26 | +1.83% | 3K | 1.24% |
| 25 | TWST | Twist Bioscienc... | 25.61 | +6.00% | 7.11K | 1.06% |
| 26 | QGEN | Qiagen N.V. | 46.07 | +0.13% | 3.56K | 0.99% |
| 27 | SUVPF | Sartorius AG | 198.85 | -24.42% | 713 | 0.99% |
| 28 | VCYT | Veracyte, Inc. | 31.86 | +3.37% | 4.76K | 0.90% |
| 29 | RGEN | Repligen Corpor... | 119.51 | -0.6% | 1.28K | 0.90% |
| 30 | RXRX | Recursion Pharm... | 4.85 | +6.83% | 30.62K | 0.85% |
| 31 | CPRX | Catalyst Pharma... | 20.25 | +2.58% | 6.37K | 0.76% |
| 32 | PTCT | PTC Therapeutic... | 60.96 | +4.51% | 2.18K | 0.76% |
| 33 | CRSP | CRISPR Therapeu... | 55.89 | +7.87% | 2.37K | 0.75% |
| 34 | GRAL | GRAIL, Inc. | 38.65 | +9.12% | 3.13K | 0.70% |
| 35 | BM8.DE | BioMarin Pharma... | 63.52 | +0.92% | 1.96K | 0.65% |
| 36 | BEAM | Beam Therapeuti... | 21.55 | +8.40% | 5.2K | 0.63% |
| 37 | DVAX | Dynavax Technol... | 9.74 | +0.21% | 9.47K | 0.56% |
| 38 | CDNA | CareDx, Inc | 13.53 | +1.50% | 6.29K | 0.50% |
| 39 | HNGE | Hinge Health, I... | 60.00 | +6.84% | 1.43K | 0.49% |
| 40 | TVTX | Travere Therape... | 25.00 | -8.46% | 3.45K | 0.44% |
| 41 | SDGR | Schrödinger, In... | 18.78 | +3.47% | 3.73K | 0.43% |
| 42 | BIO | Bio-Rad Laborat... | 285.71 | +3.18% | 192 | 0.33% |
| 43 | PKI | PerkinElmer, In... | 115.24 | -0.91% | 459 | 0.23% |
| 44 | CAI | Caris Life Scie... | 34.21 | +2.43% | 859 | 0.17% |
| 45 | WVE | Wave Life Scien... | 7.16 | -3.11% | 3.78K | 0.17% |
| 46 | TECH | Bio-Techne Corp... | 53.21 | +4.42% | 293 | 0.09% |
| 47 | BRKR | Bruker Corporat... | 32.07 | +5.18% | 491 | 0.09% |
| 48 | NGNE | Neurogene Inc. | 20.08 | +7.96% | 688 | 0.08% |
| 49 | TMDX | TransMedics Gro... | 116.99 | +8.54% | 104 | 0.07% |